Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
64
VRSN Quote, Financials, Valuation and Earnings
Last price:
$279.08
Seasonality move
:
1.53%
Day range:
$275.03 - $279.24
52-week range:
$167.05 - $279.94
Dividend yield:
0%
P/E ratio:
34.03x
P/S ratio:
17.08x
P/B ratio:
--
Volume:
888K
Avg. volume:
972K
1-year change:
58.96%
Market cap:
$26.1B
Revenue:
$1.6B
EPS (TTM):
$8.18
Analysts' Opinion
-
Consensus RatingVeriSign has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $265.33, VeriSign has an estimated downside of -10.9% from its current price of $278.36.
-
Price Target UpsideAccording to analysts, the highest upside price target is $294.00 representing 5.62% upside increase from its current price of $278.36.
Fair Value
-
According to the consensus of 3 analysts, VeriSign has -10.9% downside to fair value with a price target of $265.33 per share.
VRSN vs. S&P 500
-
Over the past 5 trading days, VeriSign has overperformed the S&P 500 by 10.67% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
VeriSign does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
VeriSign has grown year-over-year revenues for 60 quarters straight. In the most recent quarter VeriSign reported revenues of $402.3M.
Earnings Growth
-
VeriSign has grown year-over-year earnings for 1 quarter straight. In the most recent quarter VeriSign reported earnings per share of $2.10.
Enterprise value:
27.3B
EV / Invested capital:
-143.03x
Price / LTM sales:
17.08x
EV / EBIT:
24.73x
EV / Revenue:
17.31x
PEG ratio (5yr expected):
69.25x
EV / Free cash flow:
30.09x
Price / Operating cash flow:
29.68x
Enterprise value / EBITDA:
23.95x
Gross Profit (TTM):
$1.4B
Return On Assets:
52.38%
Net Income Margin (TTM):
50.2%
Return On Equity:
--
Return On Invested Capital:
6062.5%
Operating Margin:
67.41%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.4B | $1.5B | $1.6B | $384.3M | $402.3M | |
| Gross Profit | $1.2B | $1.3B | $1.4B | $335.2M | $352.9M | |
| Operating Income | $959.6M | $1B | $1.1B | $258.9M | $271.2M | |
| EBITDA | $1B | $1.1B | $1.1B | $282.6M | $287.6M | |
| Diluted EPS | $6.52 | $8.14 | $8.18 | $1.92 | $2.10 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $1.3B | $1.1B | $988.3M | $714.1M | |
| Total Assets | $1.8B | $2B | $1.8B | $1.7B | $1.4B | |
| Current Liabilities | $1B | $1.1B | $1.2B | $1.2B | $1.3B | |
| Total Liabilities | $3.2B | $3.3B | $3.4B | $3.4B | $3.4B | |
| Total Equity | -$1.4B | -$1.3B | -$1.6B | -$1.6B | -$2B | |
| Total Debt | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $883M | $852.1M | $936.6M | $257.3M | $291.3M | |
| Cash From Investing | $241M | -$10.8M | $107.5M | $496.4M | $317.6M | |
| Cash From Financing | -$1.1B | -$928.9M | -$1.2B | -$261.6M | -$239.9M | |
| Free Cash Flow | $856.5M | $808.2M | $906.5M | $253.5M | $285.5M | |
VRSN
Sector
Market Cap
$26.1B
$78.3M
Price % of 52-Week High
99.44%
57.88%
Dividend Yield
0%
0%
Shareholder Yield
5.02%
0.76%
1-Year Price Total Return
58.96%
-18.18%
Beta (5-Year)
0.870
0.870
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$258.42
200-day SMA
Buy
Level
$203.56
Bollinger Bands (100)
Buy
Level
203.35 - 246.81
Chaikin Money Flow
Buy
Level
391.5M
20-day SMA
Buy
Level
$251.07
Relative Strength Index (RSI14)
Buy
Level
74.67
ADX Line
Buy
Level
26.01
Williams %R
Sell
Level
-3.1225
50-day SMA
Buy
Level
$244.11
MACD (12, 26)
Buy
Level
7.26
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
259.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-6.0945)
Sell
CA Score
(Annual)
Level (-4.3873)
Buy
Beneish M-Score
(Annual)
Level (-2.953)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (11.2548)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
VeriSign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical internet infrastructure to support the domain name system, including operating two of the world’s 13 root servers that are used to route internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Stock Forecast FAQ
In the current month, VRSN has received 2 Buy ratings 0 Hold ratings, and 1 Sell ratings. The VRSN average analyst price target in the past 3 months is $265.33.
-
Where Will VeriSign Stock Be In 1 Year?
According to analysts, the consensus estimate is that VeriSign share price will drop to $265.33 per share over the next 12 months.
-
What Do Analysts Say About VeriSign?
Analysts are divided on their view about VeriSign share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that VeriSign is a Sell and believe this share price will rise from its current level to $217.00.
-
What Is VeriSign's Price Target?
The price target for VeriSign over the next 1-year time period is forecast to be $265.33 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VRSN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for VeriSign is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VRSN?
You can purchase shares of VeriSign via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase VeriSign shares.
-
What Is The VeriSign Share Price Today?
VeriSign was last trading at $279.08 per share. This represents the most recent stock quote for VeriSign. Yesterday, VeriSign closed at $278.36 per share.
-
How To Buy VeriSign Stock Online?
In order to purchase VeriSign stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 6.05% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 2.03% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 4.31% over the past day.
